Not too sure if the result is all that good.
Ignoring the continual revaluation and/or impairment of Enlitic which appears to be of such a regular occurrence that it could be considered part of normal trading - page 2 of the Directors report indicates $5.8m of Jobkeeper assistance. Given that the note to Revenue (4) only indicates Diagnostic imaging services as the majority of revenue, with only $61k being classified as "other", it would seem fair to assume that the receipt has been netted off against Wages costs.
With an NPAT of $6.2m, deducting the $5.8m and then adding back a tax impact (assumed) of $1.8m (@30%), this provides for a normalised NPAT of $2.2m on $85m revenue (up on comparative period) - compared to an NPAT of $2.7m on $81m.
Seems to be treading water for me.
Ann: FY21 Half Year Results Release, page-21
Add CAJ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
-0.010(3.28%) |
Mkt cap ! $314.4M | |||
| Open | High | Low | Value | Volume |
| 30.5¢ | 30.5¢ | 29.5¢ | $325.0K | 1.080M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1700 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 14021 | 2 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| CAJ (ASX) Chart |